Company Filing History:
Years Active: 2013-2015
Title: Vanessa French: Innovator in Cardiomyopathy Diagnostics
Introduction
Vanessa French is a prominent inventor based in Torbay, Canada. She has made significant contributions to the field of cardiomyopathy diagnostics, holding 2 patents that focus on innovative methods for diagnosing and treating this serious condition.
Latest Patents
Her latest patents include a diagnostic test for cardiomyopathy, which describes methods and compositions related to diagnosing and treating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). The patents provide methods for screening, diagnosing, or detecting a risk of developing ARVD/C by identifying the presence of a transmembrane protein 43 (TMEM43) disease-associated variant in a subject's sample. The presence of this variant indicates that the subject has ARVD/C or an increased risk of developing it compared to individuals with wild-type TMEM43.
Career Highlights
Throughout her career, Vanessa has worked with notable organizations such as Genesis Group Inc. and Memorial University of Newfoundland. Her work has been instrumental in advancing the understanding and treatment of cardiomyopathy.
Collaborations
Some of her coworkers include Terry-Lynn Young and Kathy Hodgkinson, who have contributed to her research and development efforts.
Conclusion
Vanessa French's innovative work in cardiomyopathy diagnostics highlights her dedication to improving patient outcomes through advanced medical research. Her contributions are paving the way for better diagnostic methods in the field.